Tuesday, 02 January 2024 12:17 GMT

Microbix Biosystems Inc.


(MENAFN- Baystreet) 10:21 AM EST - Microbix Biosystems Inc.: And Seegene Mexico S.A.P.I. de C.V. (Seegene Mexico), a firm focused upon transforming molecular diagnostics with innovative multiplex solutions, announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the clinical use of the AllplexTM and AnyplexTM molecular multiplex assays of Seegene Mexico for detecting infection with high-risk types of the human papilloma virus (HPV). Microbix Biosystems Inc. shares T are trading up $0.01 at $0.25.

MENAFN03122025000212011056ID1110433465



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search